Skip to content
Medical Health Aged Care

Memory Walk & Jog is heading to Mudgee!

Dementia Australia 2 mins read

What started as one event has grown to a movement across Australia, and in eight weeks Memory Walk & Jog will take place in Mudgee! 

Following requests from locals, Dementia Australia’s largest annual fundraising event is heading to Mudgee for a pop-up visit! Walkers, runners and joggers in Mudgee are invited to participate on Saturday 10 February at Lawson Park. 

Last year, more than 10,000 people walked, jogged and ran in cities and towns across Australia for people impacted by dementia and this year we’re hoping to go even bigger. We want more people to sign-up to assist us in achieving our goal of raising $2 million to help fund invaluable support, education and resources for people living with dementia, their families and carers.  

There are more than 400,000 people of all ages living with dementia in Australia. Without a medical breakthrough, the number of people living with dementia is expected to almost double in the next 30 years. Dementia is the second leading cause of death in Australia and the leading cause of death for women. Memory Walk & Jog plays an important role not only in funding support, but also in raising awareness of dementia.   

Walk or jog with us. We are in this together.  

Sign-up to walk, jog or run, or join in as a Volunteer, at a Memory Walk & Jog event at www.memorywalk.com.au.Share your Memory Walk & Jog experience on your socials and Donate today to support people living with dementia across Australia. 

If you can’t attend an event, why not organise your own group or individual walk or jog, with a My Way event. Choose your own date and location and register at www.memorywalk.com.au 

Dementia Australia is the source of trusted information, education and services for the estimated more than 400,000 Australians living with dementia, and the more than 1.5 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you. 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au.  

-Ends- 

Media contacts: Ash Blakemore, Senior Media & Communications Advisor, 0448 170 672, [email protected]. Andrea Hogan, Media and Communications Manager, 0406 904 118, [email protected] 

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines. 

Note to Editors: We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:  

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.  

Media

More from this category

  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:
  • Medical Health Aged Care
  • 13/01/2026
  • 10:08
Dementia Australia

Community grants to boost dementia-friendly initiatives across Australia

Dementia Australia has today opened applications foranewround ofCommunity Engagementgrantsforup to12dementia-friendly community initiatives. Dementia Australia CEO Professor Tanya Buchanan saidcommunity groupscouldapply for up to $10,000for…

  • Contains:
  • Medical Health Aged Care
  • 13/01/2026
  • 06:11
Merck

FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

Not intended for Canada-, UK- or US-based media DARMSTADT, Germany–BUSINESS WIRE– Merck, a leading science and technology company, announced today that the U.S. Food…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.